Alerts

As a precaution, health professionals are advised to avoid using all sizes and batches of AFT-distributed Provive and Sandoz Propofol 1% products until further investigation is complete.

Safety alert due to potential for incorrect INR results.

Safety advisory due to potential issues when used for uterine surgery in patients with fibroids.

Safety advisory due to risk of over-infusion.

Monitoring communication

Notice to hospitals and other healthcare facilities due to multiple safety issues.

The TGA has tested three samples of a product labelled VigRX For Men capsules and found that two counterfeit samples contained sildenafil

The TGA has tested four samples of a product labelled VigRX Plus tablets and found that two counterfeit samples contained tadalafil an undeclared substance